1. Home
  2. DARE vs IZM Comparison

DARE vs IZM Comparison

Compare DARE & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • IZM
  • Stock Information
  • Founded
  • DARE 2015
  • IZM 2011
  • Country
  • DARE United States
  • IZM China
  • Employees
  • DARE N/A
  • IZM N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • IZM Consumer Electronics/Video Chains
  • Sector
  • DARE Health Care
  • IZM Consumer Discretionary
  • Exchange
  • DARE Nasdaq
  • IZM Nasdaq
  • Market Cap
  • DARE 26.3M
  • IZM 28.7M
  • IPO Year
  • DARE N/A
  • IZM 2023
  • Fundamental
  • Price
  • DARE $2.52
  • IZM $2.58
  • Analyst Decision
  • DARE Strong Buy
  • IZM
  • Analyst Count
  • DARE 3
  • IZM 0
  • Target Price
  • DARE $12.50
  • IZM N/A
  • AVG Volume (30 Days)
  • DARE 443.5K
  • IZM 31.4K
  • Earning Date
  • DARE 08-11-2025
  • IZM 07-25-2025
  • Dividend Yield
  • DARE N/A
  • IZM N/A
  • EPS Growth
  • DARE N/A
  • IZM N/A
  • EPS
  • DARE N/A
  • IZM N/A
  • Revenue
  • DARE $25,909.00
  • IZM $180,553,977.00
  • Revenue This Year
  • DARE $99,756.91
  • IZM N/A
  • Revenue Next Year
  • DARE $119.77
  • IZM N/A
  • P/E Ratio
  • DARE N/A
  • IZM N/A
  • Revenue Growth
  • DARE N/A
  • IZM N/A
  • 52 Week Low
  • DARE $2.11
  • IZM $1.18
  • 52 Week High
  • DARE $4.60
  • IZM $3.19
  • Technical
  • Relative Strength Index (RSI)
  • DARE 41.75
  • IZM 59.08
  • Support Level
  • DARE $2.37
  • IZM $2.50
  • Resistance Level
  • DARE $2.54
  • IZM $2.74
  • Average True Range (ATR)
  • DARE 0.14
  • IZM 0.10
  • MACD
  • DARE -0.00
  • IZM -0.00
  • Stochastic Oscillator
  • DARE 59.56
  • IZM 73.68

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About IZM ICZOOM Group Inc.

ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.

Share on Social Networks: